Life-Threatening Pediatric Infections.
Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP
- Conclude that as newer immunizations eradicate many serious infections, we are still faced with certain pathogens that can cause severe morbidity and mortality.
- Recognize, diagnose and manage the following diseases:
- Toxic Shock Syndrome;
- Meningococcemia;
- Rocky Mountain Spotted Fever;
- Kawasaki
- Develop an approach to the patient who presents with fever and a rash.
Upper Airway Emergencies in the Pediatric Patient.
Upon completion of this session, using national Evidence Based Medicine sources including Cochrane Collaboration and published guidelines from sources including the American Academy of Pediatrics, the participant should be able to: EBM, GL, COMP
- Recommend medication therapy for selected upper airway emergencies.
- Interpret the most recent evidence-based literature in the approach to the child with croup.
- Distinguish and discriminate among the varied presentations of pediatric stridor.
Approach to Febrile Infants and Toddler.
Upon completion of this session, using published guidelines and evidence-based medicine, the participant should be able to: EBM, GL, COMP
- Assess the risks of various management strategies of febrile infants less than 2 months of age.
- Appraise recent data concerning the clinical approach to febrile young infants.
- Appraise data concerning the diagnostic evaluation of febrile children 3-24 months of age.
- Recognize the changing epidemiology of invasive bacterial infections secondary to widespread vaccination practices.
Acute Management of Childhood Asthma.
Upon completion of this session, using published practice guidelines and Cochrane EBM sources, the participant should be able to: EBM, GL, COMP
- Determine the appropriate use of albuterol by metered-dose inhaler, intermittent nebulizer, and continuous nebulizer for children with moderate and severe asthma exacerbations.
- Appropriately apply the evidence regarding levalbuterol as compared with albuterol in the treatment of childhood asthma.
- Employ recent data and recommendations for the use of steroids, magnesium sulfate, terbutaline, and ipratropium bromide in the treatment of acute asthma exacerbations.
- Recognize indications for inpatient hospitalization in children with acute asthma exacerbations.